Drugmakers are set to raise the prices of 350 drugs at the beginning of 2023. Pfizer, GlaxoSmithKline PLC, Bristol Myers Squibb, AstraZeneca PLC, and Sanofi SA are among several drugmakers set to raise prices, according to healthcare research firm 3 Axis Advisors, Reuters reported. The price hikes are in response to a number of factors, mainly inflation, supply problems, and the Biden administration's Inflation Reduction Act. https://www.washingtonexaminer.com/policy/healthcare/drugmakers-raise-prices-350-drugs